Home› Health

Kenya Insurers Pay Clinics Before Claims Clear

M
Min Park| Sep 19, 2026
mother.infergridplay.com · Health team
Kenya Insurers Pay Clinics Before Claims Clear

Kenya's Social Health Authority began operations in October 2024, replacing the National Health Insurance Fund. The new agency promised faster payments and broader coverage. For many small clinics, the cash-flow problem that defined the old system has not gone away. What changed is the mechanism: advance capitation payments now flow to empanelled facilities before claims are fully adjudicated, but the rules that gate that money determine whether a rural clinic sees any of it.

The Cash-Flow Crunch in Kenyan Clinics

The Social Health Insurance Act of 2023 created the Social Health Authority, which took over from the NHIF on 1 October 2024. The transition was meant to streamline a system where claims could sit unpaid for months. In practice, many facilities still wait weeks or longer for reimbursement. A clinic that dispenses drugs on credit and pays staff from the same account feels that lag immediately.

Small clinics carry the heaviest load. They lack the reserves that a county referral hospital can draw on. When a claim is rejected for a missing code, the facility absorbs the cost of the medicine already given. The patient rarely knows. The clinic either borrows to restock or sends the next patient to a pharmacy that charges cash up front.

This is not a new problem. The NHIF struggled with the same backlog for years. What matters now is whether the Social Health Authority's design fixes the mechanics or just renames them. The early evidence is mixed, and the operational details are where the difference lies.

How Advance Payments Actually Work

The Social Health Authority offers capitation-based prepayments to empanelled facilities. Capitation pays a set amount for each enrolled patient assigned to a clinic, per period, whether or not that patient seeks care. The rate varies by age and health status, reflecting expected utilisation. A clinic with many elderly or chronically ill patients receives more per head than one with a young, healthy roster.

The advance covers only a fraction of monthly costs. A facility still needs fee-for-service reimbursements for procedures and medicines outside the capitation package. Those claims go through adjudication, and that is where the delays accumulate. The advance keeps the lights on. It does not restock the pharmacy.

Capitation has a known effect on behaviour. It can reduce unnecessary procedures because the clinic keeps the difference between the capitation payment and the cost of care. It can also encourage under-provision, because every test ordered eats into the same fixed sum. The balance depends on how the rate is set and how closely quality is monitored.

The published capitation rates translate to roughly KES 1,000–1,500 per member per month, with adjustments for age and chronic conditions. For a clinic with 500 enrolled patients, that is a monthly advance in the range of KES 500,000–750,000. Salaries for two nurses and a clerk can consume most of that, leaving little for drugs. The advance is not designed to cover the full cost of care; it is a bridge. But for facilities without other income, the bridge is the whole road.

Rules That Gate the Money

Prior authorization is required for many procedures before the Social Health Authority will pay. A clinic must submit a request, wait for approval, then perform the service. For an elective surgery, that sequence is workable. For a patient with acute pain, the wait is a clinical problem.

Formulary restrictions limit which medicines are reimbursable. If a clinician prescribes a drug outside the list, the claim is rejected. The patient pays cash or goes without. The formulary is meant to control costs and steer prescribing toward proven treatments. It also forces clinicians to choose between the right drug and the covered drug.

Claims with missing codes are rejected outright. A single digit in the wrong field can void a month of work. The appeals process adds weeks to the payment cycle. A small clinic without a dedicated billing officer rarely appeals. It writes off the claim and moves on.

This site has argued that community health workers can deliver depression care in settings where specialists are scarce. The same logic applies to billing: the task does not require a specialist, but it does require someone whose job it is.

Who Gets Paid First and Why

Large hospitals with billing teams clear claims faster. They have staff who know the portal, track rejections, and file appeals on time. A county referral hospital may employ several people whose only job is claims management. That capacity is not available to a health centre with two nurses and a clerk.

Rural clinics lack the staff to navigate online portals. Connectivity is unreliable. Training on the new system was uneven. A facility that cannot log in cannot submit a claim, and a claim not submitted is a claim not paid. The equity gap between urban and rural access widens with each rejected submission.

Some counties are piloting direct facility financing, where money goes straight to the clinic rather than through a county treasury. The approach reduces the lag but requires local accounting capacity. Where that capacity exists, clinics report faster restocking. Where it does not, the funds sit unspent.

A related piece on training health workers to read spirometry makes a similar point about task-shifting. The bottleneck is rarely the clinical skill. It is the administrative scaffolding around it.

Evidence from Similar Reforms

Capitation reforms in low- and middle-income settings show mixed results. Some programmes reduce unnecessary procedures and stabilise facility budgets. Others shift costs to patients through informal fees or drug stockouts. The outcome depends on the capitation rate, the scope of the package, and how quickly claims outside the package are paid.

Payment delays are consistently linked to higher out-of-pocket spending. When a clinic waits months for reimbursement, it cannot buy drugs on credit indefinitely. Suppliers demand cash. The clinic passes that demand to the patient, who pays at the counter or delays care.

No single model fits all contexts. A capitation rate that works for a dense urban clinic may bankrupt a rural one with high transport costs and low patient volume. The design has to account for geography, not just population.

The trade-off is real. A generous advance payment reduces clinic borrowing but risks overpayment if enrollment data is wrong. A tight advance protects the insurer's balance sheet but pushes the cash-flow problem back to the facility. Someone holds the risk, and the question is who.

Kenya's experience echoes reforms elsewhere in the region. In Ghana, the National Health Insurance Scheme has grappled with similar delays, and in Tanzania, the Community Health Fund has faced comparable challenges. The common thread is that advance payments alone do not solve the problem; the administrative capacity to manage them matters just as much. A clinic that cannot track its own claims will struggle regardless of how the money flows.

What Policymakers and Clinics Can Do

Publish a firm thirty-day adjudication deadline so clinics can plan their cash flow.

Exempt a standard list of common procedures from prior authorization to cut the administrative load on small facilities.

Allow paper claims during the transition for clinics with unreliable electricity or connectivity.

Ring-fence a portion of the capitation advance specifically for drug procurement to keep pharmacies stocked.

Track clinic cash-flow metrics alongside immunisation and stockout data on national dashboards.

This article is informational and does not constitute personalised medical, legal, or financial advice. Readers should consult qualified professionals for guidance on specific situations.

How do you feel about this?
Happy
Happy
34%
Love
Love
31%
Excited
Excited
26%
Sad
Sad
6%
Angry
Angry
3%
Feedback

Found a problem or have a suggestion? Let us know. You can leave your email for a follow-up.

Health

›
In Nigeria, Drug-Resistant Typhoid Outlasts Chloramphenicol's Comeback

In Nigeria, Drug-Resistant Typhoid Outlasts Chloramphenicol's Comeback

In Nigeria, chloramphenicol's return to formulary lists collides with resistant Salmonella Typhi. Why culture-confirmed diagnosis and vaccines matter more than the drug's price tag.

Insurance

›
Check a Specialty MGA's Carrier Panel Before Renewing Binding Authority

Check a Specialty MGA's Carrier Panel Before Renewing Binding Authority

A binding authority can renew unchanged while the carrier panel behind it shifts. Here is how to trace premium flow, ceded reinsurance and claims control before you sign.

Copyright 2019 - 2026 mother.infergridplay.com